Roche Hit With $137M Verdict For Infringing Lab Test Patents

Law360 (November 25, 2019, 9:59 PM EST) -- A Delaware federal jury late Monday hit Roche Diagnostics Corp. with a roughly $137.3 million verdict for willfully infringing three of Meso Scale Diagnostic LLC's laboratory testing system patents, Meso's counsel said.

The decision came after a six-day trial in front of U.S. District Judge Leonard P. Stark, during which Meso argued it was owed royalties for Roche's global sales of testing systems.

"We’re thrilled with the jury’s verdict and feel they made a fair and just decision," Meso's attorney John M. Hughes of Bartlit Beck LLP told Law360.

In an emailed statement from Meso’s counsel team, they said the "verdict...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS